Announcements Trials
Browse Landscape

Phase

Phase 2 47Phase 1 27Phase 3 12Phase 1/2 10Phase NA 3Phase 4 3

Status

Completed 3Unknown 2Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 3

Interventions

Exercise 216Blood Specimen Collection 122Surveys and Questionnaires 117Standard of Care 114Magnetic Resonance Spectroscopy 113Early Intervention, Educational 108Educational Status 102Methods 101Radiotherapy 94Radiosurgery 76Counseling 72Control Groups 64Biopsy 61Acupuncture Therapy 60Therapeutics 57Psychiatric Rehabilitation 55Resistance Training 53Saline Solution 49Cyclophosphamide 48Palliative Care 46Yoga 41Practice Guidelines as Topic 41Cognitive Behavioral Therapy 41Metformin 40Interviews as Topic 40Drug Therapy 37Surgical Procedures, Operative 36Radiofrequency Ablation 35Dexmedetomidine 35Patient Navigation 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Completed × regorafenib × Clear all
NCT02175095 2024-10-04

[18F]FLT-PET as a Predictive Imaging Biomaker of Treatment Responses to Regorafenib

Asan Medical Center

Phase NA Completed
68 enrolled 15 charts
Gastrointestinal

Colorectal Neoplasms

NCT01996969 2019-02-22

Identification of Predictive Biomarker of Regorafenib in Refractory Colorectal Cancer

Seoul National University Hospital

Phase NA Completed
117 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03698253 2018-10-05

Metastatic Colorectal Cancer Treated With Regorafenib and FOLFIRI

Kaohsiung Medical University Chung-Ho Memorial Hospital

Phase NA Completed
41 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡